Khalid Salahuddin

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Chiesi (United States)(Current)

Brigham and Women's Hospital

Harvard University

Khalid Salahuddin is an author at Chiesi (United States) specializing in myocardial infarction pharmacotherapy, interventional cardiology, and p2y12 receptor inhibitors.

Publications per year

2021–2022

Publications

Cangrelor Use Patterns and Transition to Oral P2Y <sub>12</sub> Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry

Jennifer A. Rymer, Deepak L. Bhatt, Dominick J. Angiolillo et al. · Journal of the American Heart Association · 2022 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective

I. Jensen, Elizabeth S C Wu, Philip L. Cyr et al. · American Journal of Cardiovascular Drugs · 2021 · 11 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

1–2 of 2